ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

INMB INmune Bio Inc

11.29
0.45 (4.15%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
INmune Bio Inc INMB NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.45 4.15% 11.29 09:00:00
始値 安値 高値 終値 前日終値
10.83 10.83 11.73 11.29 10.84
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2522:00GLOBEINmune Bio Inc. Announces $9.7 Million Registered Direct..
2024/4/2321:00GLOBEINmune Bio Inc. Announces 24-Month Stability Validation of..
2024/4/2221:00GLOBEINmune Bio Inc. Raises Approximately $4.8 Million in Gross..
2024/4/0821:00GLOBEINmune Bio Inc. Presents Data on INB03’s Role as an Immune..
2024/3/2905:01GLOBEINmune Bio Inc. Announces Year End 2023 Results and Provides..
2024/3/2705:01GLOBEINmune Bio Inc. to Report Fourth Quarter 2023 Financial..
2024/3/1321:00GLOBEINmune Bio CSO and Co-Founder Mark Lowdell, Ph.D. Receives..
2024/3/0522:00GLOBEINmune Bio Reports Significant EEG Improvement in..
2024/2/1223:00GLOBEINmune Bio to Participate in the Oppenheimer 34th Annual..
2024/2/0623:00GLOBEINmune Bio to Participate in Baird’s Biotech Discovery..
2024/1/3022:02EDGAR2Form 8-K - Current report
2024/1/3022:00GLOBEINmune Bio Announces FDA Removal of Clinical Hold for..
2024/1/1622:30GLOBEELEVAI Labs, Inc. Acquires Worldwide License Agreement for..
2024/1/0306:00EDGAR2Form 8-K - Current report
2024/1/0222:00GLOBEINmune Bio Announces First Patient Dosed in a Phase 1/2..
2023/12/1906:15EDGAR2Form 8-K - Current report
2023/12/1906:05EDGAR2Form 8-A12B/A - Registration of securities [Section 12(b)]:..
2023/12/1906:01EDGAR2Form 8-K - Current report
2023/12/1906:01GLOBEINmune Bio Provides Update Regarding Global Alzheimer’s..
2023/11/3006:00EDGAR2Form 8-K - Current report
2023/11/2922:00GLOBEINmune Bio Inc. Demonstrates that INB03 Enhances the Uptake..
2023/11/2806:00EDGAR2Form 8-K - Current report
2023/11/2722:00GLOBEINmune Bio Receives EMA’s Authorization in France and Spain..
2023/11/1606:13EDGAR2Form 8-K - Current report
2023/11/1523:00GLOBEINmune Bio Inc. Announces Expansion of Phase II Clinical..
2023/11/1401:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0205:13EDGAR2Form 8-K - Current report
2023/11/0205:10GLOBEINmune Bio Inc. Announces Third Quarter 2023 Results and..
2023/11/0205:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0105:25EDGAR2Form 8-K - Current report
2023/10/3121:00GLOBEINmune Bio Inc. Patent Claims Covering INB16 Cell Line and..
2023/10/3022:07GLOBEINmune Bio Inc. Presents Preclinical Data at SITC 2023..
2023/10/1721:00GLOBEINmune Bio Inc. Presents New Biomarker and Feasibility Data..
2023/10/1622:00GLOBEINmune Bio Inc. to Report Third Quarter 2023 Financial..
2023/9/0722:10EDGAR2Form 8-K - Current report
2023/9/0722:00GLOBEINmune Bio Inc. to Present at Baird Global Healthcare..
2023/9/0605:00EDGAR2Form 8-K - Current report
2023/9/0521:00GLOBEINmune Bio Inc. Announces Approval of Clinical Trial..
2023/8/1705:41EDGAR2Form 8-K - Current report
2023/8/1705:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/8/0905:01EDGAR2Form 8-K - Current report
2023/8/0805:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0805:00GLOBEINmune Bio Inc. Announces Second Quarter 2023 Results and..
2023/8/0219:02EDGAR2Form 8-K - Current report
2023/8/0121:00GLOBEINmune Bio Inc. to Present at the BTIG Virtual ..
2023/7/3121:00GLOBEINmune Bio, Inc. to Report Second Quarter 2023 Financial..
2023/7/2805:43EDGAR2Form 8-K - Current report
2023/7/1505:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1305:00EDGAR2Form 8-K - Current report
2023/7/1302:23EDGAR2Form 144 - Report of proposed sale of securities

最近閲覧した銘柄

Delayed Upgrade Clock